L. Roper

Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak — United States, December 31, 2019–February 4, 2020

L. Rotz, A. Schuchat, M. Killerby, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022

R. Link-Gelles, B. Bell, M. Daley, 2022, MMWR. Morbidity and mortality weekly report.

Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020

Michael Bell, Clive Brown, Rebecca Dahl, 2020, MMWR. Morbidity and mortality weekly report.

Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022

Matthew M. Cole, I. Spicknall, A. Gundlapalli, 2022, MMWR. Morbidity and mortality weekly report.

Safety and Effectiveness of Maternal COVID-19 Vaccines Among Pregnant People and Infants

C. Olson, Andrea J. Sharma, S. Ellington, 2023, Obstetrics and Gynecology Clinics of North America.

Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2022

Matthew M. Cole, Elizabeth A Torrone, E. Banerjee, 2022, MMWR. Morbidity and mortality weekly report.

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 202

R. Link-Gelles, R. Wiegand, N. Shang, 2023, MMWR. Morbidity and mortality weekly report.

Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.

R. Link-Gelles, B. Bell, H. Talbot, 2022, MMWR. Morbidity and mortality weekly report.

Populations receiving optimally fluoridated public drinking water--United States, 1992-2006.

D. Fleming, S. Solomon, Susan F. Davis, 2008, MMWR. Morbidity and mortality weekly report.

Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Testing Program, United States, July 2022–February 2023

R. Link-Gelles, R. Wiegand, N. Shang, 2023, MMWR. Morbidity and mortality weekly report.

Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022

Sarah A. Meyer, B. Bell, H. Talbot, 2022, MMWR. Morbidity and mortality weekly report.

The FDA Funding Crisis

A. Zapantis, R. Speth, S. Bellam, 2014, The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians.

Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

H. Talbot, C. Kotton, S. Long, 2023, MMWR. Morbidity and mortality weekly report.